Population Pharmacokinetics and Dose Optimization Based on Renal Function of Rivaroxaban in Thai Patients with Non-Valvular Atrial Fibrillation

Low-dose rivaroxaban has been used in Asian patients with direct oral anticoagulants (DOACs) eligible for atrial fibrillation (AF). However, there are few pharmacokinetic (PK) data in Thai patients to support precise dosing. This study aimed to develop a population PK model and determine the optimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Singkham, Noppaket, Phrommintikul, Arintaya, Pacharasupa, Phongsathon, Norasetthada, Lalita, Gunaparn, Siriluck, Prasertwitayakij, Narawudt, Wongcharoen, Wanwarang, Punyawudho, Baralee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414338/
https://www.ncbi.nlm.nih.gov/pubmed/36015370
http://dx.doi.org/10.3390/pharmaceutics14081744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414338/
https://www.ncbi.nlm.nih.gov/pubmed/36015370
http://dx.doi.org/10.3390/pharmaceutics14081744

Ejemplares similares